NASDAQ:NBRV
Nabriva Therapeutics plc
- Stock
Last Close
1.41
31/07 20:00
Market Cap
4.55M
Beta: 1.55
Volume Today
706.54K
Avg: 12.53K
PE Ratio
−0.08
PFCF: −0.17
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 6.50M - | 7.75M 19.20% | 2.86M 63.04% | 27.22M 850.28% | 35.67M 31.06% | ||||||
cost of revenue | 70K - | 766K 994.29% | 13.15M 1,616.45% | 28.58M 117.38% | |||||||
gross profit | 6.50M - | 7.68M 18.12% | 2.10M 72.68% | 14.07M 570.54% | 7.09M 49.62% | ||||||
selling and marketing expenses | |||||||||||
general and administrative expenses | 3.91M - | 3.46M 11.69% | 7.82M 126.15% | 13.44M 71.86% | 29.47M 119.35% | 41.74M 41.64% | |||||
selling general and administrative expenses | 3.91M - | 3.46M 11.69% | 7.82M 126.15% | 13.44M 71.86% | 29.47M 119.35% | 41.74M 41.64% | 62.48M 49.69% | 55.28M 11.52% | 51.65M 6.58% | 45.26M 12.36% | |
research and development expenses | 10.11M - | 8.59M 15.05% | 22.73M 164.57% | 47.99M 111.15% | 49.62M 3.38% | 82.29M 65.85% | 26.41M 67.90% | 15.10M 42.83% | 12.63M 16.37% | 14.26M 12.93% | |
other expenses | 34.30M - | 77.82K 99.77% | 2.86M 3,573.65% | 55K 98.08% | 492K 794.55% | -272K 155.28% | -1.73M 537.13% | -2.16M 24.81% | -1.68M 22.38% | -1.27M 24.54% | |
cost and expenses | 6.74M - | 9.89M 46.76% | 26.84M 171.25% | 55.05M 105.12% | 73.77M 34.01% | 120.88M 63.86% | 87.24M 27.83% | 68.99M 20.92% | 75.74M 9.79% | 86.84M 14.65% | |
operating expenses | 6.74M - | 9.89M 46.76% | 26.84M 171.25% | 55.05M 105.12% | 73.77M 34.01% | 120.88M 63.86% | 87.17M 27.89% | 68.22M 21.73% | 62.60M 8.25% | 58.26M 6.93% | |
interest expense | 5.55M - | 6.98M 25.92% | 14.59M 108.87% | 75K 99.49% | 43K 42.67% | 133K 209.30% | 3.64M 2,639.85% | 1.74M 52.39% | -901K 151.93% | 698K 177.47% | |
ebitda | 28.06M - | -9.75M 134.75% | -17.24M 76.78% | -54.42M 215.71% | -72.53M 33.28% | -114.09M 57.31% | -79.02M 30.74% | -64.85M 17.93% | -48.53M 25.17% | -54.70M 12.72% | |
operating income | 22.31M - | -9.77M 143.76% | -23.98M 145.52% | -55.05M 129.58% | -73.77M 34.01% | -114.38M 55.05% | -79.49M 30.50% | -66.13M 16.81% | -48.53M 26.61% | -51.17M 5.45% | |
depreciation and amortization | 197.46K - | 152.00K 23.02% | 150.88K 0.74% | 233K 54.43% | 432K 85.41% | 510K 18.06% | 470K 7.84% | 1.27M 170.85% | 637K 49.96% | -3.53M 654.00% | |
total other income expenses net | 28.53M - | 781.90K 97.26% | 2.86M 265.65% | -783K 127.39% | 492K 162.84% | -272K 155.28% | -3.17M 1,066.91% | -3.22M 1.42% | -432K 86.58% | -4.44M 928.70% | |
income before tax | 16.55M - | -16.18M 197.77% | -31.82M 96.66% | -55.56M 74.59% | -73.00M 31.39% | -114.73M 57.16% | -82.66M 27.95% | -69.34M 16.11% | -48.96M 29.40% | -55.62M 13.60% | |
income tax expense | 1.07M - | 87.55K 91.83% | -438.41K 600.75% | -672K 53.28% | 1.35M 301.64% | 49K 96.38% | 101K 106.12% | 139K 37.62% | 490K 252.52% | 1.57M 220.00% | |
net income | 15.48M - | -16.27M 205.11% | -31.39M 92.91% | -54.89M 74.88% | -74.36M 35.46% | -114.78M 54.37% | -82.76M 27.89% | -69.48M 16.05% | -49.45M 28.83% | -57.19M 15.64% | |
weighted average shs out | 108.82K - | 108.82K 0% | 42.34K 61.09% | 85.91K 102.94% | 119.32K 38.89% | 203.18K 70.28% | 296.80K 46.07% | 513.80K 73.12% | 1.73M 237.48% | 2.68M 54.67% | |
weighted average shs out dil | 108.82K - | 108.82K 0% | 42.34K 61.09% | 85.91K 102.94% | 119.32K 38.89% | 203.18K 70.28% | 296.80K 46.07% | 513.80K 73.12% | 1.73M 237.48% | 2.68M 54.67% | |
eps | 142.25 - | -149.52 205.11% | -741.38 395.84% | -638.90 13.82% | -623.15 2.47% | -564.91 9.35% | -278.86 50.64% | -135.23 51.51% | -28.52 78.91% | -21.32 25.25% | |
epsdiluted | 130.92 - | -149.52 214.21% | -741.38 395.84% | -638.90 13.82% | -623.15 2.47% | -564.91 9.35% | -278.86 50.64% | -135.23 51.51% | -28.52 78.91% | -21.32 25.25% |
All numbers in USD (except ratios and percentages)